SP Biotech Etf Analysis

XBI -  USA Etf  

USD 90.03  1.94  2.11%

The big decline in price over the last few months for SP Biotech SPDRmay raise some interest from stockholders as it is trading at a share price of 90.03 on 21,242,200 in trading volume. The ETF money managers failed to add value to investors and positioning the etf supply of money to exploit market volatility in December. However, diversifying your holdings with SP Biotech or any similar etfs can still protect your portfolios during high-volatility market scenarios. The etf standard deviation of daily returns for 90 days investing horizon is currently 2.29. The current volatility is consistent with the ongoing market swings in December 2021 as well as with SP Biotech SPDR unsystematic, company-specific events.
Check out Your Current Watchlist.

SP Biotech Etf Analysis 

 
Refresh
The SP Biotech etf analysis report makes it easy to digest most publicly released information about SP Biotech and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. SP Biotech Etf analysis module also helps to analyze the SP Biotech price relationship with some important fundamental indicators such as market cap and management efficiency.

SP Biotech Etf Analysis Notes

SP Biotech is is formed as Regulated Investment Company in the United States. ETF is managed and operated by SSgA Funds Management, Inc.. The fund has 191 constituents with avarage daily trading value of 12.6 M. The fund charges 0.35 percent management fee with total expences of 0.35 percent of total asset. The fund generated five year return of 13.0%. SP Biotech SPDR keeps 99.8% of net assets in stocks. This fund last dividend was 0.017 per share. The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. SP Biotech is traded on NYSEArca Exchange in the United States. For more information please call the company at 866-787-2257.

Sector Exposure (%)

Investment Allocations (%)

SP Biotech SPDR Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. SP Biotech's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding SP Biotech SPDR or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
SP Biotech SPDR generated a negative expected return over the last 90 days
The fund keeps 99.8% of its net assets in stocks

SP Biotech Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as SP Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading SP Biotech SPDR backward and forwards among themselves. SP Biotech's institutional investor refers to the entity that pools money to purchase SP Biotech's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Mcguire Investment Group LlcFund Units177.7 K19.9 M
Note, although SP Biotech's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Management Efficiency

SP Biotech management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.

Top Etf Constituents

Information
Ratio
Value
At Risk
SAGE
Sage Therapeutic Com 0.0035 (3.66) 
VKTX
Viking Thera(0.17) (5.98) 
LGND
Ligand Pharm(0.0316) (5.85) 
NTRA
Natera Inc(0.22) (6.59) 
ADMS
Adamas Pharmaceuticals 0.14 (3.43) 
ARRY
Array Technologies(0.15) (7.44) 
BTAI
Bioxcel Therapeutics(0.12) (7.69) 
RARE
Ultragenyx Pharmaceu(0.05) (4.06) 
MCRB
Seres Therapeutics 0.08 (6.56) 
BIIB
Biogen Inc(0.09) (3.78) 
INO
Inovio Pharma(0.21) (6.66) 
NVAX
Novavax(0.08) (11.60) 
SRNE
Sorrento Therpt(0.18) (7.24) 
GBT
Global Blood Ther(0.0088) (5.48) 
MRNA
Moderna(0.14) (11.87) 
FATE
Fate Therapeutics(0.12) (7.54) 
ALLO
Allogene Therapeutics(0.07) (7.70) 
SRPT
Sarepta Therapeutics(0.10) (5.64) 
NBIX
Neurocrine Bioscienc(0.17) (3.97) 
NVTA
Invitae Corp(0.24) (8.41) 

Institutional Etf Holders for SP Biotech

Information
Ratio
Value
At Risk
DMSZX
F
Destinations Multi Strategy(0.06) (0.50) 
DEVDX
F
Driehaus Event Driven(0.09) (1.07) 
NNAIX
F
AINN Fund(0.19) (2.67) 
DMSFX
F
Destinations Multi Strategy(0.06) (0.49) 
PAPPX
F
Papp Small Mid-Cap(0.08) (1.99) 
FXTAX
F
PSI Tactical Growth(0.06) (0.82) 
TCMSX
F
Tcm Small Cap(0.16) (3.42) 
HOTFX
F
Fundx Aggressive Upgrader(0.13) (2.39) 
CAPTX
F
Canterbury Portfolio Thermostat(0.1) (0.98) 
FMPCX
F
Nuveen Small Cap(0.17) (3.45) 
FIMPX
F
Nuveen Small Cap(0.18) (3.45) 
FRMPX
F
Nuveen Small Cap(0.18) (3.43) 
FMPFX
F
Nuveen Small Cap(0.18) (3.44) 
ETFCX
F
Stadion Market Opportunity(0.10) (1.62) 
ETFAX
F
Stadion Tactical Growth(0.1) (1.60) 
ETFOX
F
Stadion Tactical Growth(0.1) (1.62) 
SECT
E
Northern Lights IV 0.0093 (1.80) 
TSCGX
F
Thrivent Small Cap(0.17) (2.79) 
CMSYX
F
Cavalier Tactical Economic 0.48 (0.07) 
HHCAX
F
Highland LongShort Healthcare(0.05) (1.64) 

Technical Drivers

As of the 23rd of January, SP Biotech owns the risk adjusted performance of (0.16), and Mean Deviation of 1.7. Concerning fundamental indicators, the technical analysis model makes it possible for you to check potential technical drivers of SP Biotech SPDR, as well as the relationship between them. Strictly speaking, you can use this information to find out if the etf will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We have analyzed nineteen technical drivers for SP Biotech, which can be compared to its peers in the sector. Please validate SP Biotech SPDR standard deviation, as well as the relationship between the maximum drawdown and expected short fall to decide if SP Biotech SPDR is priced correctly, providing market reflects its prevailing price of 90.03 per share.

SP Biotech SPDR Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Exponential Moving Average is calculated by weighting recent values of SP Biotech SPDR more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

SP Biotech Predictive Daily Indicators

SP Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of SP Biotech etf daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

SP Biotech Forecast Models

SP Biotech time-series forecasting models is one of many SP Biotech's etf analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary SP Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About SP Biotech Etf Analysis

Etf analysis is the technique used by a trader or investor to examine and evaluate how SP Biotech stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling SP Biotech shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as SP Biotech. By using and applying SP Biotech Etf analysis, traders can create a robust methodology for identifying SP Biotech entry and exit points for their positions.
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. SP Biotech is traded on NYSEArca Exchange in the United States.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding SP Biotech to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Instant Ratings Now

   

Instant Ratings

Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module
Check out Your Current Watchlist. Note that the SP Biotech SPDR information on this page should be used as a complementary analysis to other SP Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for SP Biotech Etf analysis

When running SP Biotech SPDR price analysis, check to measure SP Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SP Biotech is operating at the current time. Most of SP Biotech's value examination focuses on studying past and present price action to predict the probability of SP Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move SP Biotech's price. Additionally, you may evaluate how the addition of SP Biotech to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
The market value of SP Biotech SPDR is measured differently than its book value, which is the value of SP Biotech that is recorded on the company's balance sheet. Investors also form their own opinion of SP Biotech's value that differs from its market value or its book value, called intrinsic value, which is SP Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SP Biotech's market value can be influenced by many factors that don't directly affect SP Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SP Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine SP Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SP Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.